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Abstract
Background: Thyroid cancer is a tumor with a low but growing incidence in Spain. This study
sought to depict its spatial municipal mortality pattern, using the classic model proposed by Besag,
York and Mollié.
Methods: It was possible to compile and ascertain the posterior distribution of relative risk on the
basis of a single Bayesian spatial model covering all of Spain's 8077 municipal areas. Maps were
plotted depicting standardized mortality ratios, smoothed relative risk (RR) estimates, and the
posterior probability that RR > 1.
Results: From 1989 to 1998 a total of 2,538 thyroid cancer deaths were registered in 1,041
municipalities. The highest relative risks were mostly situated in the Canary Islands, the province
of Lugo, the east of La Coruña (Corunna) and western areas of Asturias and Orense.
Conclusion: The observed mortality pattern coincides with areas in Spain where goiter has been
declared endemic. The higher frequency in these same areas of undifferentiated, more aggressive
carcinomas could be reflected in the mortality figures. Other unknown genetic or environmental
factors could also play a role in the etiology of this tumor.
Background
At the European level, Spain ranks midway in terms of
thyroid cancer (TC) incidence. This is a tumor that is far
more frequent among women than among men. In recent
years, incidence rate per 100,000 population has
increased from 1.73 to 2.22 in the periods 1993–1996 [1]
and 1997–2000 [2] in men, and from 3.63 [1] to 5.69 [2]
per 100,000 in women. In the 1990s, mortality due to this
tumor in males registered a statistically significant [2]
mean annual increase of 1.21%, which in 2004 rose to a
rate, standardized to the European population, of 0.33 per
100,000 population [3]. In women, however, TC mortal-
ity declined significantly by an average of 0.39% per
annum [2], until reaching a rate of 0.49 per 100,000 pop-
ulation in 2004 [3]. Prevalence attributable to cases diag-
nosed in the preceding 5 years has reached a figure of
1559 cases in men and 4901 in women [4]. In Spain, TC
is the tumor with the highest survival rate in women (86%
at 5 years), and ranks second after testicular cancer in men
(82%) [5].
Most thyroid tumors are epithelial and are classified into
well-differentiated thyroid tumors (which include, in
order of frequency, papillary, follicular, and oncocytic car-
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ponent) and anaplastic carcinomas (the most aggressive
type) [6]. The best-known TC risk factor is exposure to
ionizing radiation, whether through therapeutic irradia-
tion or environmental pollution. Nevertheless, there are
also epidemiologic studies that associate TC with clinical
history of benign thyroid diseases, such as goiter or ade-
nomas [7,8], hormonal and reproductive factors [8-12],
dietary factors (such as iodine deficiency or high con-
sumption of goitrogenic foods) [8,13-16], and genetic fac-
tors [17].
Thyroid cancer mortality in Spain is not distributed uni-
formly, being more pronounced in iodine-deficient geo-
graphic areas, mainly in the north-west of the country and
the Pyrenees [18]. Spatial epidemiology is a relatively new
discipline that seeks to describe, quantify and explain geo-
graphic variations in diseases and their relationship with
factors generally of environmental origin. Advances in
computation techniques, the ever-greater availability of
georeferenced incidence and mortality data at different
levels, the development of new statistical and epidemio-
logic methods for cluster research [19,20], and the grow-
ing public interest in the effects of environmental
pollution, are reinforcing the potential of this discipline.
Analysis of small areas (generally districts or municipali-
ties) improves the interpretation of results and the capac-
ity to detect local effects linked to environmental
problems, while reducing ecologic biases [21]. This study
sought to study municipal distribution of TC mortality in
Spain using these techniques, and to discuss the possible
relationship between such distribution and the risk fac-
tors outlined above.
Methods
Individual entries for the period 1989–1998, correspond-
ing to deaths in towns and cities throughout Spain due to
thyroid cancer (International Classification of Diseases,
ICD-9 rubric 193), were used as the case source. These
data were supplied by the National Statistics Institute
(NSI) (Instituto Nacional de Estadística) for the production
of a municipal cancer mortality atlas.
The municipal populations, broken down by age group
(18 groups) and sex, were drawn from the 1991 census
and 1996 municipal voters rolls. These years correspond
to the midway points of the two quinquennia that com-
prise the study period (1989–1993 and 1994–1998). The
person-years for each five-year period were estimated by
multiplying these populations by 5.
Standardized mortality ratios (SMRs) were calculated as
the ratio between observed and expected deaths. For the
calculation of expected cases, the overall Spanish mortal-
ity rates for the above two 5-year periods were applied to
each town's person-years by age group, sex and quinquen-
nium.
To draw up these maps, smoothed municipal relative risks
(RRs) were calculated using the autoregressive conditional
model proposed by Besag, York and Mollié. This model
was introduced by Clayton and Kaldor (1987), developed
by Besag, York and Mollié [22], and subsequently applied
in the field of ecologic studies [23]. Such models are based
on fitting spatial Poisson models with two random-effect
terms that take the following into account: a) the effects
which vary in a structured manner in space (municipal
contiguity); and, b) a component that models the effects
which vary among municipalities in an unstructured man-
ner (municipal heterogeneity) [24]. The model takes the
following form
Oi ~ Po(Ei λi)
log(λi) = α + hi + bi
where: λi is the relative risk in area I; Oi is the number of
deaths in area I; α is the intercept; Ei are the expected
number of cases; hi is the municipal heterogeneity term;
and bi is the spatial term.
The models were fitted using Bayesian Markov Chain
Monte Carlo simulation methods with improper priors
[25]. Posterior distributions of relative risk were obtained
using WinBugs [26]. The criterion of contiguity needed for
the model was adjacency of municipal boundaries. Con-
vergence of the simulations was verified using the BOA
(Bayesian Output Analysis) R program library [27]. Given
the great number of parameters of the models, the conver-
gence analysis was performed on a randomly selected
sample of 10 towns and cities, taking 4 strata defined by
municipal size. Convergence of the estimators was
achieved before 100,000 iterations. In the present study, a
"burn-in" (iterations discarded to ensure convergence) of
300,000 iterations was performed, and the posterior dis-
tribution was derived using 5,000 iterations. The CPU
time on a Pentium 2 GHz was 18 hours.
A Geographic Information System (GIS) was used to cre-
ate municipal maps of SMRs, smoothed RR estimates, and
the posterior probability that RR > 1. In the case of this
last-mentioned indicator, we applied Richardson's crite-
rion [21], which recommends that probabilities over 0.8
be deemed significant.
To facilitate the location of regions cited in this paper, a
map showing the respective Spanish Autonomous
Regions and provinces is attached (see Additional data file
1).Page 2 of 9
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From 1989 through 1998, a total of 2538 TC deaths were
registered in Spain (809 in men and 1729 in women).
Cases were registered in 1041 towns and cities. Using
these data we were able to compile and ascertain the pos-
terior distribution of relative risk on the basis of a single
spatial model that included all of Spain's 8077 towns and
cities and the 46398 adjacencies existing between them.
The maps in the Annex show 8225 rather than the 8077
NSI-coded towns and cities, due to the fact that there are
148 stretches of territory in Spain which are regarded
either as state-owned (communally exploited areas tradi-
tionally known as parzonerías, and military zones), munic-
ipal common land (pastures, common and heath), or
land belonging jointly to two or more municipalities
(mancomunidad; union or league of towns). To allow the
coding of terrain not identified by the NSI, the code of the
nearest town was allocated to such areas so that the spatial
analyses could be performed.
The SMRs are shown in Figure 1, the distribution of
smoothed RRs for TC is plotted in Figure 2, and the poste-
rior probability of RR being greater than 1 is depicted in
Figure 3. The SMR map shows the polarization of the dis-
tribution towards its extremes (towns with and without
cases), with no specific pattern being clearly discernable.
The "noise" present in this map, deriving from the insta-
bility of the indicator, was eliminated by the smoothing
procedure (Figure 2).
Notable in the smoothed map (Figure 2) is the concentra-
tion of higher TC mortality in the north-west of the coun-
try, mainly in the province of Lugo, the east of La Coruña
(Corunna), and western areas of Asturias and Orense.
With the exception of the Canary Islands, there was no
other region with such high mortality values.
Table 1 reports information on the most representative
towns and cities with excess TC mortality. The selection
criteria chosen were as follows: any municipality with at
Municipal distribution of thyroid cancer mortalityFigure 1
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expected cases of 2 or more, an RR of over 1.2, and a pos-
terior probability of 0.8 or more of RR exceeding 1. A total
of 39 towns and cities, situated in 12 provinces, met these
criteria. In all, 75% of highlighted localities lay in the
north-west of the country and were mainly concentrated
in 2 Autonomous Regions, namely, Galicia and Asturias.
Outside this area, attention should be drawn to the raised
risk observed in some towns in the Canary Islands and in
the City of Seville, with 62 observed versus 40 expected
cases. Puerto del Rosario (in the Canaries), followed by El
Ferrol (in Galicia), were the towns with the highest RRs in
Spain.
Discussion
The results of this study reveal a higher risk of death due
to TC in the north-west of the country and the Canary
Islands. The pattern observed in this study is in line with
an earlier study undertaken at a provincial level, in which
the provinces of Lugo, Asturias, Las Palmas de Gran
Canaria, and Corunna featured among the 5 with highest
mortality in the period 1975–1995 [18]. Analysis at a
municipal level has however led to the detection of small
areas of risk, which had been masked at a provincial level.
When separate analyses were performed for men and
women, a similar geographic pattern was in evidence for
both sexes (data not shown).
Standard errors of SMR are inversely dependent on the
number of expected cases. This implies that the most
extreme SMRs occur in small population areas and are
based on a small number of cases. Maps of unsmoothed
SMRs are therefore dominated by "green areas" (low RRs)
and "red areas" (high RRs), most likely reflecting random
variation. The smoothed map, however, tends to elimi-
nate part of the random variability, solely highlighting
those areas in which the risk is concentrated, so that a
town with no TC deaths could be regarded as having
Municipal distribution of thyroid cancer mortality in SpainFigure 2
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vice-versa. As a result, this could give rise to false positives
(enhancing the risk of some towns), as occurs in certain
Galician areas, or false negatives (attenuating the risk of
others), as occurs in certain areas of Badajoz, Ciudad Real,
Albacete, Cordoba, Jaen and Murcia.
When it comes to interpreting the results, a number of
limitations must be borne in mind. In the first place, mor-
tality is not the best indicator of the frequency of appear-
ance of TC, since this tumor registers a high rate of
survival. Yet, the lack of a cancer registry for the country as
a whole, forces us to use this data source. Moreover, TC
includes different histological types with different degrees
of aggressiveness, hence mortality possibly reflects the
incidence of the most aggressive tumor types in particular.
Given that the highest risk appear in remote rural areas,
mortality could also reflect differential accessibility to
health care. Finally, TC, like all solid tumors, has a long
latency period, so that the mortality pattern observed in
our study would thus reflect the distribution of possible
risk factors present in Spain some decades ago.
As stated above, the results of this study essentially reveal
a greater risk of TC in the north-west of mainland Spain
and in the Canary Islands, both traditionally areas of
endemic goiter. The first descriptions of endemic goiter in
Spain date back to the latter part of the 19th century. In
1927, Dr. Gregorio Marañón first reported the problem
and, thanks to the strong pressure subsequently brought
to bear by a certain scientific societies and groups of
experts, a Royal Decree was passed in 1983 requiring the
iodization of packaged table salt. In 1990, Spain commit-
ted itself to eradicating iodine deficiency by the year 2000.
Yet, there is still no nationwide legislation governing the
universal iodization of salt and Spain suffers from mild-
Municipal distribution of thyroid cancer mortalityFigure 3
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affected areas being located in Galicia and certain parts of
the Province of Leon [29].
Among the possible factors causing goiter are: first, a low
intake of iodine (basically present in saltwater fish and
seafood); second, congenital failures in the biosynthesis
of thyroid hormones; and, third, antithyroid or goitro-
genic substances, which interfere with the correct assimi-
lation of iodine and are found in foods (thiocyanates,
isothiocyanates and thioglucosides present in vegetables
such as cabbage, Brussels sprouts and cauliflower) and
drinking water (contaminated with E. Coli or compounds
of a geologic origin) [30]. Some authors are, however, of
the opinion that the role of goitrogenic substances in the
etiology of endemic goiter is very limited [31].
Insofar as the relationship between TC and endemic goiter
is concerned, iodine deficiency has been described as pos-
sibly having oncogenic power due to sustained hyperstim-
ulation of the thyroid induced by elevated levels of
thyroid stimulating hormone (TSH). This can stimulate
clones of follicular cells with an altered phenotype that
renders them prone to proliferate until autonomous
growth clones appear which may, in turn, give rise to can-
cer [32]. Although there are no data to show that overall
Table 1: Selected towns and cities with excess thyroid cancer mortality. *Spain 1989–1998.
Autonomous Region Province City or Town Obs Exp SMR Smoothed RR P (RR > 1)
Andalusia Seville Seville 62 39.65 1.56 1.298 0.984
Asturias Asturias Corvera de Asturias 3 0.91 3.30 1.489 0.978
Gijón 27 18.89 1.43 1.415 0.991
Langreo 7 3.96 1.77 1.501 0.979
Lena 6 1.08 5.57 1.582 0.994
Mieres del Camino 6 3.97 1.51 1.481 0.995
Oviedo 24 14.03 1.71 1.522 0.998
Tineo 4 1.34 2.99 1.562 0.991
Canary Islands Palmas Puerto del Rosario 3 0.51 5.91 3.955 0.962
Santa Lucía 5 1.10 4.54 1.626 0.925
Telde 6 2.91 2.06 1.337 0.863
Santa Cruz de Tenerife Arona 4 0.82 4.87 1.692 0.935
Guia de Isora 4 0.54 7.45 1.621 0.940
Paso (El) 4 0.46 8.64 1.734 0.920
Santa Cruz de Tenerife 14 10.64 1.32 1.289 0.856
Cantabria Santander Camaleño 4 0.14 28.99 1.584 0.982
Castile & Leon Leon Cistierna 3 0.40 7.43 1.338 0.929
Catalonia Barcelona Calella 5 0.86 5.85 1.410 0.839
Gerona Sant Feliu de Guixols 4 1.18 3.40 1.452 0.836
Galicia Corunna Corunna 21 15.95 1.32 1.288 0.918
Ferrol 13 6.17 2.11 1.963 0.995
Melide 3 0.72 4.18 1.770 0.998
Mesia 4 0.32 12.66 1.644 0.995
Naron 5 1.96 2.55 1.768 0.990
Oza dos Rios 3 0.34 8.72 1.691 0.994
Porto do Son 3 0.78 3.85 1.327 0.850
Lugo Barreiros 3 0.41 7.35 1.804 0.992
Begonte 3 0.46 6.59 1.798 0.999
Cervantes 3 0.29 10.42 1.607 0.996
Folgoso do Courel 3 0.24 12.61 1.595 0.999
Friol 5 0.55 9.17 1.824 0.999
Mondoñedo 3 0.65 4.61 1.747 0.997
Monforte de Lemos 5 2.03 2.47 1.522 0.987
Orense Carballiño (O) 4 1.03 3.87 1.620 0.994
Ourense 11 7.01 1.57 1.556 0.996
Ribadavia 4 0.53 7.50 1.550 0.985
Pontevedra Silleda 3 0.94 3.21 1.460 0.968
Vigo 24 16.10 1.49 1.308 0.934
Vilagarcia de Arousa 4 1.96 2.04 1.385 0.910
Obs = observed deaths; Exp = expected deaths; SMR = standard mortality ratio; Smoothed RR = smoothed relative risk; P (RR > 1) = posterior 
probability that RR > 1.
* Towns and cities that fulfill the following criteria: (Obs – Exp) > = 2; Obs >= 3; RR > 1.2 y (P(RR) > 1) >= 0.8.Page 6 of 9
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[33], some studies reported a higher risk among subjects
who live in such areas [34-36]. Furthermore, several
papers have described that iodine deficiency and iodine
excess may induce changes in the distribution of histolog-
ical types, inasmuch as areas with sufficient iodine have
been associated with a higher prevalence of papillary car-
cinoma whereas areas with iodine deficiency are associ-
ated with a higher frequency of follicular and anaplastic
thyroid cancer [33,37,38]. A possible explanation for this
phenomenon might reside in the fact that in endemic
goiter areas, i.e., traditionally mountainous areas having a
lower level of socio-healthcare development, differenti-
ated TC might not have been diagnosed in time. While
there is no clear evidence that remedying iodine defi-
ciency by iodine prophylaxis reduces TC incidence/mor-
tality [37], some studies have nonetheless shown that
iodine prophylaxis results in less aggressiveness in its bio-
logic behavior and a regression in the frequency of
advanced tumor stages within the same histologic type
[33].
In our results, we have detected a higher risk of death due
to TC in Galicia. Rural Galicia has historically been one of
the endemic goiter regions in Spain. Up until relatively
recently, it was not unusual to encounter subjects with
large-sized goiters in endemic areas inland and along the
main access routes into Galicia (via Orense or Lugo) [39].
Among the factors that possibly favored this endemic dis-
ease are: low iodine content in the water; low consump-
tion of fish in mountainous areas; lack of road and rail
transport and telecommunications; and a diet based on
plants of the genus Brassica [40,41]. It is worth mention-
ing that habitants of Galician consume much more green
leafy and other vegetables (mainly, different varieties of
turnip top, Brussels sprouts and cabbage) than the
national average [42]. Furthermore, low levels of sele-
nium in the diet can alter the hormonal thyroid metabo-
lism, either through formation of free radicals or through
inhibition of the deiodinase that converts thyroxine (T4)
into triiodothyronine (T3) [43,44]. Indeed, some studies
addressing cancer in human beings suggest that sub-nor-
mal selenium levels in the diet could raise the risk of
developing cancer [45]. As a consequence of its acid soils,
Galicia is regarded as a selenium-poor area; levels in new-
borns are low and increase with age [46]. Of all the Gali-
cian provinces, Lugo registered the highest mortality rates.
This was also the province where Garrido et al. reported
the highest prevalence of goiter in Galicia [39], a com-
plaint that continues to be frequent despite the institu-
tional campaign that was launched in 1985, advocating
the use of iodized salt [47,48].
Asturias is classified as a region having Grade I endemic
goiter (i.e., palpable though not visible when the neck is
normally at rest) [29]. In 1983, an iodized salt campaign
targeted the entire Asturian population and made its use
compulsory in all school canteens. After 18 years of iodine
prophylaxis, prevalence of goiter has fallen appreciably
[49]. In 1985, Martínez Rodríguez et al, in a study on TC
in Asturias, detected a high proportion of undifferentiated
forms. They observed that anaplastic forms were more fre-
quent in endemic goiter areas, and in general, that all
types were more common in cases where patients were or
had been residing in such areas; but if the same patients
were to be transferred to urban/industrial areas they
would preferably develop a differentiated carcinoma [50].
In this respect, the higher TC mortality observed in the
western region of Asturias could be explained by the
higher frequency of more aggressive undifferentiated
forms in this area. Subsequently, the Health & Healthcare
Services Board of the Directorate-General of Public Health
for the Principality of Asturias recorded 517 cases of TC in
the period 1982–1993, distributed mainly throughout the
southern and eastern municipal areas of the region [51].
There are hardly any studies that address TC status or prev-
alence of goiter in the Canary Islands in the years preced-
ing this study. In one undertaken in 1986 in Las Palmas
Province, it was the Island of Gran Canaria that registered
the highest incidence of goiter, principally in mountain-
ous areas. Puerto del Rosario on Fuerteventura (the town
with the highest mortality rate in our study) and Santa
Lucía on Gran Canaria were two of the districts having a
greater percentage of admissions due to goiter. Nearly
10% of such cases developed into carcinomas, mainly fol-
licular [52]. Furthermore, in the period 1993–1995, this
tumor's incidence rate in the Canary Islands was far higher
among women than among men (7.05 and 1.65 per
100,000 person-years respectively)[18].
There are other Spanish regions which have traditionally
been regarded as endemic goiter areas, yet nonetheless
failed to register such a marked risk in TC mortality in our
study. Pre-eminent among these are certain mountain dis-
tricts in the Pyrenees, Cadiz, Huelva, Seville and Las Hur-
des [29,53]. This finding has led us to consider the
possible existence of causes, unknown until now, which
might account for the geographic pattern observed in this
study.
The best-evidenced etiologic factor implicated in TC is
ionizing radiation. Medical irradiation of the head and
neck, particularly during childhood, has been linked to
increases in this type of tumor [32,54-56]. Indeed, it has
been estimated that the risk of a thyroid nodule proving
malignant is 30%–40% if the person in question under-
went radiation during his/her childhood [32]. Formerly, it
was common practice to irradiate in order to treat benign
childhood affections (such as ringworm of the scalp,Page 7 of 9
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or even cancer, fundamentally of head and neck. In this
respect, it is noteworthy that the geographic patterns for
TC bear some similarity with the patterns displayed by
tumors of the buccal cavity and pharynx, with the latter
being more common in west Andalusia, the Canary
Islands and the Basque Country [57]. To our knowledge,
however, there is no evidence of the existence of differ-
ences in clinical practice in Spain. Moreover, the geo-
graphical distribution of natural radiation in Spain does
not correspond to the patterns plotted for highest mortal-
ity in our study [58].
Furthermore, the possible influence of genetic factors on
the distribution of TC mortality should not be ruled out.
These factors are particularly important in medullary thy-
roid cancer, where one third of cases are linked to heredi-
tary syndromes [17]. However, nonmedullary tumors can
also be associated with the so-called syndrome of familial
nonmedullary thyroid cancer [59]. In this regard, the areas
concerned -relatively isolated and virtually inaccessible
until a few years ago- might possibly be characterized by a
certain tendency towards endogamy.
Conclusion
In conclusion, municipal maps can be a useful tool from
a public health standpoint, since they allow for detection
of risk areas that might otherwise be masked at a provin-
cial level and identification of possible etiologic factors.
The geographic study of TC mortality at a municipal level
has enabled us to detect a very marked pattern in the
north-west of the country and in the Canary Islands, areas
traditionally designated as goiter-endemic. The hypothet-
ical presence of more aggressive histologic types in such
areas, as well as the possible action of other unknown
genetic or environmental factors might be possible etio-
logic hypotheses to be borne in mind in future geographic
studies.
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